Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02434133 · ClinicalTrials.gov registry record
Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 110
- Enrollment target
NCT02434133 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 110 participants.
The verdict
NCT02434133 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The investigators proposed study is the first of its kind. The investigators will measure measles, mumps, rubella, tetanus, diphtheria and pertussis antibodies in patients on the current IBD treatment modalities and compare the vaccine antibody concentrations and correlate them with time since immunization.
Interventions
- PROCEDURE Blood Draw/Data Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02434133
The ClinicalTrials.gov registry entry for NCT02434133 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw/Data Collection is the first listed.
NCT02434133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02434133 about?
NCT02434133 is a clinical study titled "Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients". The investigators proposed study is the first of its kind. The investigators will measure measles, mumps, rubella, tetanus, diphtheria and pertussis antibodies in patients on the current IBD treatment modalities and compare the vaccine antibody concentrations and correlate them with time since immun...
What is the current status of trial NCT02434133?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2015-04. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02434133?
The interventions under investigation include: Blood Draw/Data Collection (PROCEDURE).
Who is sponsoring clinical trial NCT02434133?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.